Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study

Clin Kidney J. 2019 Feb 11;13(4):722. doi: 10.1093/ckj/sfz009. eCollection 2020 Aug.

Authors

William G Herrington, David Preiss, Richard Haynes, Maximilian von Eynatten, Natalie Staplin, Sibylle J Hauske, Jyothis T George, Jennifer B Green, Martin J Landray, Colin Baigent, Christoph Wanner

Abstract

[This corrects the article DOI: 10.1093/ckj/sfy090.].

© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.

Publication types

Published Erratum

Grants and funding